1833-201-407 Ph2 Clinical Study (M21-467)
ClinicalTrials.gov NCT04499248
Research payments
$82,684
Through program year 2024, $82,684 in research payments was reported against 1833-201-407 Ph2 Clinical Study (M21-467), across 24 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT04499248
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $82,684 | 24 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- David Wirta Newport Beach, CA Named on 1 payment
- Husamuddin Ansari Boston, MA Named on 1 payment
- Mark Slabaugh Columbus, OH Named on 1 payment
- Frank Cotter Roanoke, VA Named on 1 payment
- Mujtaba Qazi Chesterfield, MO Named on 1 payment
- Ronald Frenkel Stuart, FL Named on 1 payment
- Damien Goldberg Torrance, CA Named on 1 payment
- Jacob Brubaker Sacramento, CA Named on 1 payment
- James Paauw Lynchburg, VA Named on 1 payment
- Eran Duzman Irvine, CA Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.